Rare diseases
Investigational molecules
Locations
Back to Germany390 clinical trials in Erlangen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy
GermanyStudy on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet
GermanyStudy of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer
GermanyPhase III trial evaluating ianalumab with background drug combination in patients with Sjögren's disease
GermanyRinatabart Sesutecan with or without bevacizumab versus standard platinum‑based chemotherapy drug combination in patients with recurrent platinum‑sensitive ovarian cancer
GermanyStudy of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy
GermanyPhase 2 study of MK-7262 and enlicitide decanoate in adults with high lipoprotein(a)
GermanyEfficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis
GermanyRandomized trial of elecoglipron with dapagliflozin versus placebo in adults with type 2 diabetes mellitus and impaired renal function
GermanyStudy of BGB-43395 with letrozole versus CDK4/6 inhibitor drug combination with letrozole in patients with untreated advanced HR‑positive HER2‑negative breast cancer
GermanyEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
GermanyStudy of LY3484356 (imlunestrant) with Tamoxifen Citrate and Goserelin Acetate in Premenopausal Women with ER‑Positive, HER2‑Negative Early Breast Cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on breast cancer treatments, including studies of new therapies for HR-positive and HER2-negative variants. Additional research encompasses lung cancer and various lymphomas.
Studies evaluate novel therapeutic combinations and targeted treatments for improved patient outcomes.
Comprehensive research into various autoimmune disorders, including lupus erythematosus, psoriasis, and systemic conditions. Studies focus on innovative therapeutic approaches.
Trials aim to develop more effective treatments for chronic autoimmune conditions.
Clinical investigations focusing on acute cerebral ischemic stroke and multiple system atrophy. Research emphasizes innovative therapeutic approaches for better patient outcomes.
Studies evaluate new therapeutic agents and treatment strategies for neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
